BARINTHUS BIOTHERAPEUT
1.3802
08-11月-24 15:55:30
15 分の遅延
株式
-0.0913
-6.20%
本日の幅
1.3800 - 1.5100
ISIN
N/A
ソース
NASDAQ
-
Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
06 11 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
31 10 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
01 10 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
24 9 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
08 8 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
12 6 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024
22 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
13 5 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
01 5 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
18 4 2024 16:10:00 提供 Nasdaq GlobeNewswire
-
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
20 3 2024 08:15:23 提供 Nasdaq GlobeNewswire
-
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
05 1 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
New partnership aims to advance vaccine against MERS coronavirus
21 12 2023 07:31:16 提供 Nasdaq GlobeNewswire
-
09 11 2023 16:24:43 提供 Nasdaq GlobeNewswire
-
Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
09 11 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
13 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
10 8 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
21 6 2023 09:03:54 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >